Further studies to characterize the biological effects of this isoform are necessary, as 145 is a strong candidate for a pro-angiogenic therapeutic for cerebrovascular diseases that avoids the detriments seen with VEGFA. Here, VEGFA is linked to cerebrovascular disorder.